Trial Profile
Multicentric Evaluator-blinded Randomized Non-inferiority Study, to Asses the Compared Efficacy, Safety and Immunogenicity of Enerceptan With Enbrel in Combination With Methotrexate for the Treatment of Patients With Rheumatoid Arthritis
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 05 Nov 2021
Price :
$35
*
At a glance
- Drugs Etanercept (Primary) ; Methotrexate
- Indications Rheumatoid arthritis
- Focus Registrational; Therapeutic Use
- Acronyms GEMENE
- Sponsors Amega Biotech
- 14 Dec 2020 Results published in the JCR: Journal of Clinical Rheumatology
- 09 Nov 2017 New trial record